Hotel-Dieu Hospital

Kingston, Ontario K7L 5G2

0 studies enrolling now · 9 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Angiotensin Converting Enzyme Inhibitor Induced Angioedema, Cancer of the Prostate, Colitis, Ulcerative, Crohn's Disease, Hormone Sensitive Prostate Cancer, Irritable Bowel Syndrome, Prostate Cancer, Ulcerative Colitis

Studies at this site

• Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) — Running, not enrolling
• Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema — Completed
• A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab — Completed
• An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis — Completed
• ELND005 in Patients With Mild to Moderate Alzheimer's Disease — Completed
• A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY) — Completed
• Study for the Treatment of Crohn's Disease With Adacolumn — Completed
• Study for the Treatment of Ulcerative Colitis With Adacolumn — Completed
• 8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS — Completed